This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CF Industries (CF) Stock Rallies 58% in 6 Months: Here's Why
by Zacks Equity Research
CF Industries (CF) gains on strong demand for nitrogen fertilizers and higher nitrogen prices.
Chemours (CC) Stock Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Chemours (CC) benefits from a rebound in demand from the pandemic-induced downturn, strong execution, cost-reduction and pricing actions.
Albemarle (ALB) Up 43% in 3 Months: What's Driving the Stock?
by Zacks Equity Research
Forecast-topping earnings performance in the first quarter and upbeat outlook for 2022 have contributed to the rally in Albemarle's (ALB) shares.
Newmont (NEM) Wraps Up Deal With Skeena to Acquire Properties
by Zacks Equity Research
Newmont (NEM) will partner with the Tahltan Nation, the Iskut community and the British Columbia government.
Ingevity (NGVT) Gains on Strong Demand, Capacity Expansion
by Zacks Equity Research
Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth.
Ashland (ASH) Launches Gafchromic LD-V1 Film, Boosts Portfolio
by Zacks Equity Research
Ashland's (ASH) latest addition, Gafchromic LD-V1 film includes improved contrast and imaging detail.
Reliance Steel's (RS) Shares Up 28% in 6 Months: Here's Why
by Zacks Equity Research
Reliance Steel (RS) benefits from strong demand across key end-use markets, a diversified product base and strategic acquisitions.
Valmont (VMI) And Ericsson Wrap Up the Buyout of ConcealFab
by Zacks Equity Research
Valmont's (VMI) buyout boosts its telecom strategy by integrating innovative 5G infrastructure and PIM mitigation solutions into its advanced infrastructure portfolio.
Zacks.com featured highlights include Eagle Pharmaceuticals, Cabot, Meritage Homes, Griffon, and APA
by Zacks Equity Research
Eagle Pharmaceuticals, Cabot, Meritage Homes, Griffon, and APA are part of Screen of the Week article.
Why You Should Add Univar (UNVR) Stock to Your Portfolio
by Zacks Equity Research
Univar (UNVR) benefits from market share gains, operational execution, higher industrial demand, synergies of the Nexeo acquisition and a robust liquidity position.
Air Products (APD) Gains on Project Investments, Productivity
by Zacks Equity Research
Air Products (APD) is well-placed to gain from its investments in high-return industrial gas projects, project wins and efforts to boost productivity amid headwinds from higher costs.
Univar (UNVR) to be Distributor for Cabot's Carbon Black Products
by Zacks Equity Research
Univar's (UNVR) deal with Cabot adds to its current relationship and will provide customers with innovative materials and solutions.
Cabot (CBT) Shares Hit 52-week High: What's Driving It?
by Zacks Equity Research
Cabot (CBT) is gaining from a recovery in demand and strategic acquisitions.
Cabot (CBT) Up 8.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Invest In Chemours (CC) Stock Now
by Zacks Equity Research
Chemours (CC) is gaining from higher volumes on the back of strong demand, its cost and pricing actions and strong execution.
Press the Buy Button on These 5 High Earnings Yield Picks Now
by Rimmi Singhi
One could invest in high earnings yield stocks like Eagle Pharmaceuticals (EGRX), Cabot (CBT), Meritage Homes (MTH), Griffon (GFF) and APA Corp (APA) to fetch handsome long-term rewards.
Chemours (CC) Evaluates Capacity Investments for Hydrogen Economy
by Zacks Equity Research
Chemours' (CC) higher ionomers capacity would support demand growth within water electrolysis and fuel cell technology.
Kronos Worldwide's (KRO) Shares Pop 30% in 3 Months: Here's Why
by Zacks Equity Research
Kronos Worldwide (KRO) benefits from an uptick in titanium dioxide selling prices and higher volumes on the back of strong demand.
Here's Why You Should Buy Nutrien (NTR) Stock Right Now
by Zacks Equity Research
Nutrien (NTR) benefits from solid demand and higher prices for fertilizers, supported by the strength in global agriculture markets.
LyondellBasell Industries (LYB) Hikes Quarterly Dividend by 5%
by Zacks Equity Research
LyondellBasell (LYB) declares a special dividend of $5.20 per share and a quarterly dividend of $1.19 per share.
Air Products (APD) Inks Development Deal With OQ & ACWA Power
by Zacks Equity Research
Air Products' (APD) agreement is toward a multibillion-dollar investment in a world-scale green hydrogen-based ammonia manufacturing site powered by renewable energy in Oman.
Here's Why You Should Buy Huntsman (HUN) Stock Right Now
by Zacks Equity Research
Huntsman (HUN) gains on its investment in downstream businesses, differentiated product innovation and strategic acquisitions.
Univar (UNVR) & Angus Expand Distribution Deal in Europe
by Zacks Equity Research
Univar's (UNVR) agreement will provide its customers with extended access to specialty cleaning ingredients and comprehensive technical innovation and sourcing support.
Ashland (ASH) Hikes Dividend by 12%, Declares $500M Buyback
by Zacks Equity Research
Ashland (ASH) announces a quarterly cash dividend of 33.5 cents per share on its common stock.
First Majestic (AG) Inks Deal to Sell La Guitarra Silver Mine
by Zacks Equity Research
First Majestic Silver (AG) inks a deal to sell its La Guitarra Silver Mine, which had been placed under care and maintenance.